News
Based on these results, Prothena has made the decision to discontinue the development of birtamimab. Topline results were announced from a phase 3 trial evaluating birtamimab in patients with ...
The CHMP also adopted a positive opinion for Attrogy (diflunisal) for the treatment of hereditary TTR–mediated amyloidosis in adult patients with stage I or stage II polyneuropathy. The ...
Clergy attend the beatification Mass of Carlo Acutis in the Basilica of St. Francis in Assisi in Assisi, Italy, Oct. 10, 2020. (Credit: CNS photo/courtesy Diocese of Assisi- Nocera Umbra- Gualdo ...
Background: Amyloidosis cutis dyschromica (ACD) is a rare type of primary localized cutaneous amyloidosis. Non-invasive techniques can provide important clues for early diagnosis. Objectives: To ...
Dufferin County has proclaimed March as Amyloidosis Awareness Month to help bring awareness to the rare, incurable and fatal disease. During their meeting last Thursday (Feb. 13), Dufferin ...
Amyloidosis is a group of conditions that cause an abnormal protein called amyloid to build up in the body. Treatment depends on the type of amyloidosis but may include medications and organ ...
The new understanding of molecular events that drive the various forms of amyloidosis has led to the expansion of therapeutic options to prevent end-stage disease or even offer a cure, which has ...
Wainua (eplontersen) is a prescription injection medicine that slows down nerve damage in people with a type of amyloidosis called hereditary transthyretin-mediated amyloidosis (hATTR).
In people with a rare condition called light chain amyloidosis, light chain proteins—which are a component of antibodies—mutate and build up in different organs.
Care of patients with systemic immunoglobulin light chain (AL) amyloidosis has undergone transformative changes, leading to marked, steady progress in outcomes for patients over the past four decades.
There is a simple discount patient access scheme for tafamadis. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
In their study published in the Mayo Clinic Proceedings, UAB researchers collaborated with researchers from Weill Cornell Medicine and Columbia University to show that carpal tunnel syndrome preceded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results